According to Curis's latest financial reports and stock price the company's current number of shares outstanding is 5,720,789. At the end of 2023 the company had 5,720,789 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 5.72 M | 18.66% |
2022 | 4.82 M | 5.25% |
2021 | 4.58 M | 38.06% |
2020 | 3.31 M | 99.83% |
2019 | 1.66 M | 0.26% |
2018 | 1.65 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 5,647,000,000 | 98,610.16% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,057,000,000 | 35,856.58% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | 201,918,066 | 3,429.55% | ๐บ๐ธ USA |
Exelixis EXEL | 308,482,000 | 5,292.30% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | 47,261,000 | 726.13% | ๐บ๐ธ USA |
Cel-Sci
CVM | 48,470,600 | 747.27% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | 51,800,000 | 805.47% | ๐บ๐ธ USA |